Corrigendum to: Indigenous psilocybin mushroom practices: An annotated bibliography
Journal of Psychedelic Studies February 29, 2024 Nicholas Spiers, Beatriz Caiuby Labate, Anna O. Ermakova et al. correction
and has been studying rock art
Journal of Psychedelic Studies
ISSN 2559-9283
232 papers in the library · 2,809 citations · publishing 2017-2026
Papers
Psychonauts: Drugs and the making of the modern mind
Journal of Psychedelic Studies February 26, 2024 Ido Hartogsohn 4 citations
The term psychonaut has become increasingly common in recent years.Introduced in 1949 by Ernst Jünger, a German author and fellow traveler of Albert Hofmann, the word is used to describe individuals dedicated to the exploration of their mind, often with use of psychedelics.Distinct to those who experiment with psychedelics haphazardly, the title 'psychonaut' suggests an aura of method,...
Indigenous psilocybin mushroom practices: An annotated bibliography
Journal of Psychedelic Studies February 19, 2024 Nicholas Spiers, Beatriz Caiuby Labate, Anna O. Ermakova et al. 27 citations
Abstract This annotated bibliography comprises 49 texts concerning psilocybin mushroom practices developed by Indigenous peoples. The books and articles have been selected for their academic rigor, relevance, and historical significance, and to foreground overlooked research and subject matter. This includes research on a plurality of contemporary practices and evidence of historical uses, from...
Perceptions and attitudes towards psychedelic-assisted psychotherapy among health professionals, patients, and the public: A systematic review
Journal of Psychedelic Studies February 5, 2024 Alesha Wells, Merciana Fernandes, Lisa Reynolds 37 citations
Abstract Background and aims Scientific interest in the therapeutic potential of psychedelics has been experiencing significant growth. Understanding the perceptions of psychedelic assisted psychotherapy (PAP) among health professional, patients, and the public is essential to guide future research objectives, trial protocols, and identify any barriers to future implementation. Methods A...
MDMA-assisted dialectical behavioral therapy for borderline personality disorder: A qualitative study of mental health clinicians
Journal of Psychedelic Studies February 5, 2024 Ann M. Inouye, Aaron Wolfgang, Lianne T. Philhower 1 citation
Abstract In 2021, the final series of phase 3 clinical trials looking at MDMA-AT for treatment-resistant post-traumatic stress disorder (PTSD) found that 71.2% of 3,4-methylenedioxymethamphetamine (MDMA) full-dose participants no longer met criteria for PTSD. MDMA-assisted therapy is not US Food and Drug Administration (FDA) approved in treating borderline personality disorder (BPD), and while...
LSD use in the United States: Examining user demographics and their evolution from 2015–2019
Journal of Psychedelic Studies February 1, 2024 Jeremy Weleff, Akhil Anand, Elizabeth N. Dewey et al. 8 citations
Abstract Background Lysergic acid diethylamide (LSD) use has risen in the United States in recent years amid increased interest in therapeutic applications of psychedelics. Despite this, contemporary epidemiological investigations of LSD users are few. To expand the literature on this topic, we sought to characterize past-year LSD users in the United States and investigate recent demographic...
Psychedemia: Charting the future of interdisciplinary Psychedelic Studies
Journal of Psychedelic Studies December 29, 2023 Neşe Devenot, Brian A. Pace, Jason C. Slot et al. 1 citation
Amidst an unfolding resurgence of psychedelic research, there is the opportunity to discuss new approaches for integrating psychedelics into both academia and society.In partnership with the newly founded Center for Psychedelic Drug Research and Education (CPDRE) at The Ohio State University, the editors of this special issue convened the Psychedemia, 2022 conference as a rigorous...
MDMA-assisted therapy for borderline personality disorder
Journal of Psychedelic Studies December 14, 2023 Ann M. Inouye, Aaron Wolfgang, Lianne T. Philhower 1 citation
AbstractAssociated with high-risk behavior, borderline personality disorder (BPD) remains one of the field's most misunderstood, misdiagnosed, and stigmatized conditions. Individuals with BPD are frequently labeled as treatment-resistant patients. Furthermore, 25–58% of BPD individuals have a comorbid diagnosis of post-traumatic stress disorder (PTSD), and BPD may be conceptualized as a...
Perceptions of psychedelic personality change, determinants of use, setting and drug moderation: Toward a holistic model
Journal of Psychedelic Studies December 8, 2023 Brandon Weiss, Chelsea Sleep, Nicholas M. Beller et al. 11 citations
Abstract Background Studies have shown evidence for long-term effects of psychedelics on personality, but comprehensive models of psychedelic-mediated personality changes have yet to be explored. Aims The present study aims to investigate (1) perceptions of personality change in the general population, (2) moderators of perceived personality change including setting and drug type, and (3)...
Psychedelics and schizophrenia: A mystery in history
Journal of Psychedelic Studies December 2, 2023 Mark Haden, Birgitta Woods, Sarah A. Paschall 3 citations
Abstract This analysis of current and historical research and clinical reports observes that the relationship between psychedelics and schizophrenia is complex and there are reports of psychedelics benefiting this population. Specifically, lower doses of psychedelics (mostly LSD) appear to have a potential beneficial impact on the negative symptoms of schizophrenia.
Toad in the road: Biocultural history and conservation challenges of the Sonoran Desert Toad
Journal of Psychedelic Studies November 30, 2023 R Villa 5 citations
Abstract The Sonoran Desert Toad ( Incilius alvarius ) is the only vertebrate known to produce the powerful psychedelic, 5-MeO-DMT, which is easily-accessible form the animal's exterior glands. This paper seeks to present the biocultural (ecological and cultural) history, and conservation concerns of I. alvarius . Discovery of 5-MeO-DMT in I. alvarius was first reported in 1965 and 1967...
The potential of psilocybin use to enhance well-being in healthy individuals – A scoping review
Journal of Psychedelic Studies November 29, 2023 Lennart Wiepking, Eduard J. de Bruin, Alexandra Ghiţă 10 citations
Abstract Background and aims This scoping review employed a multifaceted conceptualization of well-being to examine how psilocybin use affects well-being and related sub-concepts in healthy individuals. It investigated which factors influence the relationship between psilocybin use and well-being, what research protocols have been employed, and what underlying mechanisms have been proposed in...
Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials
Journal of Psychedelic Studies November 20, 2023 Tahlia R. Harrison 23 citations
Abstract Background and aims Psychedelic-assisted therapy (P-AT) has been shown to reduce post-traumatic stress disorder (PTSD), depression, and anxiety symptoms, and is likely to be approved in the United States (US) in the coming years. However, concerns about participant safety in these early trials have surfaced, including allegations of sexual misconduct. This paper aims to illuminate how...
Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness
Journal of Psychedelic Studies November 16, 2023 Danelle Jones 48 citations
Recent years have seen a global explosion in the field of psychedelic research, popularizing of use of non-ordinary states of consciousness to aid in PTSD, anxiety and depression, end of life and a growing sense that the use of substances like MDMA, psilocybin and others may become mainstream approaches to treating persistent challenges in these marginalized populations.As we destigmatize these...
Evaluating the role of psychedelic psychotherapy in addressing societal alienation: Imaginaries of liberation
Journal of Psychedelic Studies September 25, 2023 Julien Tempone-Wiltshire, Floren Matthews 11 citations
Abstract Questions are currently being posed concerning the implications of the clinical uptake of psychedelics. While enthusiasm surrounds the potential therapeutic benefits of psychedelics and critique surrounds their appropriation to commercial ends, limited attention has been given to the role of psychedelics in generating social transformation. Herbert Marcuse contended radical change...
TESCREAL hallucinations: Psychedelic and AI hype as inequality engines
Journal of Psychedelic Studies September 25, 2023 Neşe Devenot 9 citations
Abstract Background and Aims While many scholars have called attention to similarities between the earlier SSRI hype and the ongoing hype for psychedelic medications, the rhetoric of psychedelic hype is tinged with utopian and esoteric aspirations that have no parallel in the discourse surrounding SSRIs or other antidepressants. This utopian discourse provides insight into the ways that global...
Beyond the psychedelic hype: Exploring the persistence of the neoliberal paradigm
Journal of Psychedelic Studies September 21, 2023 James R Davies, Brian A. Pace, Neşe Devenot 29 citations
Abstract Background and Aims Advocates of psychedelic medicine have positioned psychedelics as a novel therapeutic intervention that will solve the mental health crisis by liberating individuals from their entrenched habits and limiting beliefs. Despite claims for novelty, the psychedelics industry is engaging in the same profit-oriented approaches that contributed to poor clinical outcomes...
Psychedelics and critical theory
Journal of Psychedelic Studies September 21, 2023 Julien Tempone-Wiltshire, Tra-Ill Dowie 10 citations
Abstract In the monograph Philosophy and Psychedelics: Frameworks for Exceptional Experience, Hauskeller raises the important subject of individualization and alienation in psychedelic psychotherapy. Under the prevailing conditions of neoliberalism, Hauskeller contends that psychedelic-assisted psychotherapy appropriates Indigenous knowledges in an oppressive fashion, may be instrumentalised to...
Self-perception and self-recognition while looking in the mirror on psilocybin
Journal of Psychedelic Studies September 19, 2023 Sam Elias, Stephanie Spivak, Alexa Alverez et al. 1 citation
Abstract Introduction It is not known how self-perception and self-recognition are influenced when one is highly self-focused under the influence of psilocybin. Here we examine self-reports of mirror self-recognition and self-perception during a psilocybin experience. Methods Reddit posts were examined in a systematic manner. Posts that were written by individuals that ingested psilocybin and...
Negative mystical experiences
Journal of Psychedelic Studies September 11, 2023 Dax Oliver 2 citations
Abstract I propose that positive mood should not be among the criteria for determining when or if psychedelic experiences are mystical. My primary reasons are: 1) unlike rare proposed mystical criteria such as feelings of self-dissolution and time-transcendence, positive mood does not clearly separate mystical experiences from other emotionally powerful experiences like being in love; 2) other...
Microdosing psychedelics: The segregation of spiritual and scientific narratives within the r/microdosing online community
Journal of Psychedelic Studies September 11, 2023 Ioana Pop, Erwin Gielens, Hannah Kottmann 1 citation
Abstract Background and aims Microdosing psychedelics refers to the practice of repeatedly ingesting doses that do not reach the threshold for perceptual alterations. This practice has gained attention from mass media, businesses, and the general public, as evidenced by the proliferation of online communities dedicated to it. In this contribution, we examine the content generated within the...
Differences in attitudes and beliefs about psychedelic-assisted therapy among social workers, psychiatrists, and psychologists in the United States
Journal of Psychedelic Studies August 21, 2023 Stacey B. Armstrong, Adam W. Levin, Yitong Xin et al. 12 citations
Abstract Background and aims Because psychedelic-assisted therapy (PAT) is likely to be provided by interdisciplinary professional teams comprised of social workers, psychologists, and psychiatrists, understanding the acceptability of this treatment approach among these professional disciplines is essential as the treatment advances through approval processes at the Food and Drug...
Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy
Journal of Psychedelic Studies August 21, 2023 Benjamin M. Ross, James T. Neill 6 citations
Abstract Background Psilocybin, the psychoactive compound in magic mushrooms, is increasingly discussed in terms of its psychotherapeutic potential; however, little is known about community attitudes towards psilocybin assisted therapy (PAT). Aims To address the question: What are the public's attitudes towards psilocybin and psilocybin-assisted therapy? And what factors explain these...
Mescaline, Peyote and San Pedro: Is sustainability important for cacti consumers?
Journal of Psychedelic Studies August 19, 2023 Liam Engel, Monica J Barratt, Jason Ferris et al. 7 citations
Abstract Background and Aims Both Peyote and San Pedro cacti contain mescaline, a classical psychedelic eliciting mystical and visual effects, but only Peyote is a vulnerable species. We sought to address the questions 1; do people who use Peyote substitute with San Pedro, and vice versa, and; 2. how popular is the use of wild harvested mescaline cactus compared with the use of cultivated...
Psychedelics, embodiment, and intersubjectivity
Journal of Psychedelic Studies August 14, 2023 K. Blevins 2 citations
Research into the social aspects of set and setting have demonstrated that race is a significant factor in psychedelic experiences for racially marginalized populations. Yet, many studies of psychedelic-induced experiences continue to proceed without collecting data on or considering the influence of race or other social categories. These approaches abstract subjectivity from its embodied and...